Profile data is unavailable for this security.
About the company
Keymed Biosciences Inc is a China-based biotechnology company. The Company focuses on the independent discovery and development of innovative biological therapies that address underserved medical needs in the autoimmune and oncology therapeutic areas. The Company has mastered in-house drug discovery and development technologies, including an innovative antibody discovery platform and a proprietary novel T cell engager (nTCE) bispecific antibody platform. The Company has also established a fully integrated platform covering the key functions of biopharmaceutical development. The Company's main products include CM310, CM326 and CMG901.
- Revenue in HKD (TTM)381.99m
- Net income in HKD-387.67m
- Incorporated2018
- Employees897.00
- LocationKeyMed Biosciences Inc18 Biotown Middle Road Building D2Chengdu Tianfu International BiotownCHENGDU 610219ChinaCHN
- Websitehttps://www.keymedbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 872.99m | 110.24m | 6.76bn | 948.00 | 20.35 | 0.8876 | -- | 7.74 | 0.1071 | 0.1071 | 0.829 | 2.46 | 0.2852 | 1.44 | 1.62 | 920,872.30 | 3.59 | 7.03 | 4.35 | 9.05 | 91.40 | 92.17 | 12.59 | 17.26 | 3.94 | 568.37 | 0.0062 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | 0.00 |
| Tong Ren Tang Technologies Co Ltd | 7.31bn | 636.69m | 7.21bn | 4.10k | 11.33 | 0.9702 | 5.27 | 0.9868 | 0.4971 | 0.4971 | 5.71 | 5.80 | 0.5212 | 0.9835 | 5.68 | 1,781,785.00 | 7.64 | 7.68 | 12.10 | 12.32 | 42.04 | 43.50 | 14.65 | 16.11 | 2.37 | -- | 0.1443 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | 0.0178 |
| China Shineway Pharmaceutical Group Ltd | 4.87bn | 1.05bn | 7.56bn | 3.44k | 6.60 | 0.996 | 6.17 | 1.55 | 1.38 | 1.38 | 6.45 | 9.18 | 0.5073 | 1.44 | 6.31 | 1,418,035.00 | 10.89 | 8.03 | 14.15 | 9.77 | 75.15 | 74.55 | 21.47 | 17.87 | 2.98 | -- | 0.0411 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| Beijing Tong Ren Tang Chinese Medicine | 1.52bn | 540.39m | 8.10bn | 798.00 | 14.99 | 2.10 | 12.04 | 5.31 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Everest Medicines Ltd | 135.85m | -910.99m | 8.28bn | 432.00 | -- | 1.52 | -- | 60.97 | -2.91 | -2.91 | 0.434 | 16.78 | 0.0203 | 2.25 | 4.57 | 314,475.40 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| Shanghai Henlius Biotech Inc | 5.82bn | 589.04m | 9.03bn | 3.64k | 15.38 | 3.82 | 9.25 | 1.55 | 1.08 | 1.08 | 10.66 | 4.35 | 0.5731 | 1.95 | 9.10 | 1,600,203.00 | 5.80 | -8.59 | 12.47 | -14.14 | 72.64 | 71.77 | 10.12 | -27.37 | 0.3786 | 6.48 | 0.6512 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| Cansino Biologics Inc | 372.38m | -1.60bn | 9.41bn | 1.49k | -- | 0.9096 | -- | 25.27 | -6.48 | -6.48 | 1.51 | 23.03 | 0.0332 | 2.37 | 0.4619 | 249,248.10 | -18.93 | -4.27 | -26.69 | -5.60 | -253.78 | -- | -569.97 | -27.72 | 1.86 | -- | 0.3381 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
| Lepu Biopharma Co Ltd | 243.11m | -23.84m | 9.46bn | 429.00 | -- | 9.78 | 121.57 | 38.91 | -0.0144 | -0.0144 | 0.1465 | 0.5831 | 0.0917 | 1.06 | 1.62 | 566,680.70 | -1.23 | -- | -1.91 | -- | 87.45 | -- | -13.45 | -- | 0.7201 | 0.1388 | 0.4549 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
| Keymed Biosciences Inc | 381.99m | -387.67m | 10.07bn | 897.00 | -- | 3.13 | -- | 26.36 | -1.49 | -1.49 | 1.45 | 11.52 | 0.0906 | 0.7314 | 26.14 | 425,854.90 | -9.16 | -- | -10.05 | -- | 89.59 | -- | -101.04 | -- | 9.18 | -- | 0.123 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
| InnoCare Pharma Ltd | 796.72m | -681.00m | 10.23bn | 1.09k | -- | 1.17 | -- | 12.84 | -0.4038 | -0.4038 | 0.4721 | 4.37 | 0.073 | 1.39 | 3.39 | 731,608.40 | -6.38 | -13.41 | -8.08 | -15.36 | 82.61 | 85.99 | -87.42 | -172.16 | 4.13 | -- | 0.1582 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
| AIM Vaccine Co Ltd | 1.28bn | -1.40bn | 10.35bn | 1.62k | -- | 2.63 | -- | 8.08 | -1.16 | -1.16 | 1.06 | 3.24 | -- | -- | -- | 788,805.90 | -- | -- | -- | -- | 75.88 | -- | -164.24 | -- | 0.7583 | -14.04 | 0.3158 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 6.79bn | 2.15bn | 11.14bn | 4.62k | 5.18 | 1.30 | 4.59 | 1.64 | 2.44 | 2.44 | 7.72 | 9.73 | 0.5111 | 3.62 | 4.09 | 1,470,441.00 | 15.07 | 8.03 | 24.46 | 11.81 | 79.21 | 79.97 | 29.48 | 20.80 | 1.30 | 11.16 | 0.2475 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| Luye Pharma Group Ltd | 6.63bn | 574.57m | 11.25bn | 5.27k | 19.48 | 0.832 | 8.40 | 1.70 | 0.1535 | 0.1535 | 1.78 | 3.59 | 0.247 | 2.42 | 3.60 | 1,257,505.00 | 2.17 | 2.80 | 3.56 | 4.45 | 68.44 | 70.53 | 8.78 | 10.39 | 1.21 | 3.10 | 0.3931 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| SciClone Pharmaceuticals (Holdings) Ltd | 3.40bn | 1.21bn | 11.34bn | 1.05k | 9.72 | 3.21 | 14.84 | 3.33 | 1.86 | 1.86 | 5.23 | 5.62 | 0.7585 | 3.56 | 3.83 | 3,242,118.00 | 26.97 | 27.09 | 33.34 | 36.32 | 74.67 | 76.06 | 35.55 | 35.43 | 4.50 | 27.95 | 0.01 | -- | 14.76 | 17.50 | 31.16 | 15.96 | -- | -- |
| Zai Lab Ltd | 2.08bn | -2.61bn | 13.14bn | 2.18k | -- | 2.07 | -- | 6.31 | -2.70 | -2.70 | 2.16 | 6.40 | 0.2364 | 2.51 | 5.38 | -- | -29.66 | -37.72 | -34.97 | -42.72 | 64.08 | 64.75 | -125.46 | -282.44 | 4.41 | -- | 0.00 | -- | 24.03 | 360.03 | 24.51 | -- | -3.45 | -- |
Data as of May 07 2024. Currency figures normalised to KeyMed Biosciences Inc's reporting currency: Hong Kong Dollar HKD
10.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 05 Apr 2024 | 5.91m | 2.11% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2023 | 4.38m | 1.57% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2023 | 4.04m | 1.44% |
| E Fund Management Co., Ltd.as of 30 Jun 2023 | 2.90m | 1.04% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2023 | 2.71m | 0.97% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 2.55m | 0.91% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 2.43m | 0.87% |
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2023 | 2.18m | 0.78% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 2.10m | 0.75% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2023 | 1.42m | 0.51% |
More ▼
Data from 30 Jun 2023 - 02 May 2024Source: FactSet Research Systems Inc.
